Author: BusinessWire

ACI and MACI treatments could be improvised with the first of its kind feat by Edogawa Hospital, Tokyo
TOKYO–(BUSINESS WIRE)–Regenerative therapy to treat knee joint damages gets a boost with a breakthrough technology of growing ideal type of cartil…

PARIS–(BUSINESS WIRE)–Today, Excelya has announced that it has appointed Nathalie Doize as Director of Operations and Rudolph Rosenberg as Chief Financial Officer at Excelya. Following strong growth in 2020, Nathalie will aim to harmonize operations …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company is voluntarily withdrawing the U.S. indication for Tecentriq® (atezolizumab) in prior-platinum treated m…

FDA has set Prescription Drug User Fee Act (PDUFA) target action date of 23 August 2021

If approved, KORSUVA™ injection would be first therapy for treatment of pruritus in hemodialysis patients

ST.GALLEN, Switzerland & STAMFORD, Conn.–(BUSINESS W…

CHAPEL HILL, N.C.–(BUSINESS WIRE)–#CART–UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy,…

“PSG Complete” is the latest in a series of drug management innovations from PSG
DALLAS–(BUSINESS WIRE)–#drug–Pharmaceutical Strategies Group (PSG), an EPIC company, is innovating in the drug management space again with the launch of its PSG Comple…

PARSIPPANY, N.J.–(BUSINESS WIRE)–Diaceutics PLC, (AIM: DXRX), today announces the appointment of Nikita Lynn to Vice President of Finance. She has been promoted to this role following her tenure as Senior Director of Corporate Advancement.

In her ne…

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Chief Financial Officer, Executive Vice President, Global Supply, at the Barclays Global Healthcare …

DUBLIN–(BUSINESS WIRE)–The “United States Active Pharmaceutical Ingredient Market, By Method of Synthesis, By Source, By Distribution Channel, By Therapeutic Application, By Form, By Molecule Type, By Potency, By Drug Type, By Region, Competition For…

Topline results from Phase 1/2 study on track for March 2021

Individual and cumulative data seen to-date show Trappsol® Cyclo™ to be well tolerated with a favorable safety profile for all dose groups and to have encouraging signals in efficacy

Pivot…